Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 14/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29911790 | 1.00 | TRPA1 (0.59) | TRPA1CYP1A2MAOAMAOBCYP2A6 | |
| Hydrochloric Acid SCHEMBL11023474 | 0.98 | TRPA1 (0.57) | TRPA1CYP1A2MAOAMAOBCYP2A6 | |
| SCHEMBL3707900 | 0.79 | TRPA1 (0.46) | TRPA1CYP1A2MAOAMAOBCYP2A6 | |
| Morphanthridine SCHEMBL1150250 | 0.74 | TRPA1 (1.00) | TRPA1 | |
| SCHEMBL3632749 | 0.74 | TRPA1 (0.59) | TRPA1MAOAMAOB | |
| SCHEMBL14361835 | 0.74 | TRPA1 (0.53) | TRPA1CYP1A2MAOAMAOB | |
| SCHEMBL4202476 | 0.74 | TRPA1 (0.53) | TRPA1CYP1A2MAOAMAOB | |
| Morphanthridine SCHEMBL1509656 | 0.72 | TRPA1 (0.96) | TRPA1 | |
| SCHEMBL1725093 | 0.72 | PARP1 (0.32) | TRPA1 | |
| SCHEMBL8115304 | 0.72 | TRPA1 (0.32) | TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874481-A | 1-phenyl-pyrrole [1,2-b ] isoquinoline-3-ketone compound and application thereof | 贵州省天然产物研究中心 | 2023-10-13 | — | — | CN | claimed |
| CN-110204491-B | Synthesis method of chiral 3, 4-dihydroisoquinolinone compound | 台州学院 | 2021-02-19 | — | — | CN | claimed |
| EP-2588104-B1 | ISOINDOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | MERCK SHARP & DOHME (US) | 2014-12-10 | — | — | EP | claimed |
| CN-1218472-A | Pharmaceutically useful compounds | ASTRA PHARMA PROD (GB) | 1999-06-02 | — | — | CN | claimed |
| EP-0457243-A1 | Novel tricyclic compounds | SYNTEX (U.S.A.) INC. (US) | 1991-11-21 | — | — | EP | claimed |
| EP-4323356-A1 | AMINO-SUBSTITUTED HETEROCYCLES FOR TREATING CANCERS WITH EGFR MUTATIONS | Nuvalent, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| WO-2024015262-A1 | FUSED RING KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| CN-114163385-B | Method for promoting oxidation of tetrahydroisoquinoline compounds to lactam compounds by using surfactant | 新乡市润宇新材料科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-116874481-A | 1-phenyl-pyrrole [1,2-b ] isoquinoline-3-ketone compound and application thereof | 贵州省天然产物研究中心 | 2023-10-13 | — | — | CN | disclosed |
| WO-2023173014-A1 | KRAS INHIBITORS AND THEIR USE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023173016-A1 | KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023173017-A1 | KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2002036599-A1 | THIENO[2,3-C]ISOQUINOLINES FOR USE AS INHIBITORS OF PARP | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-05-10 | — | — | WO | disclosed |
| WO-2002000626-A1 | FUSED AZEPINE DERIVATIVES AND THEIR USE AS ANTIDIURETIC AGENTS | FERRING B.V. (NL) | 2002-01-03 | — | — | WO | disclosed |
| EP-1098650-A1 | BENZOQUINOLIZIDINE AND BENZOINDOLIZIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF | AMERICAN BIOGENETIC SCIENCES, INC. (US) | 2001-05-16 | — | — | EP | disclosed |
| US-6183934-B1 | FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-1019409-A1 | POLY(ADP-RIBOSE) POLYMERASE (\"PARP\") INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE | GUILFORD PHARMACEUTICALS INC. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-2000004905-A1 | BENZOQUINOLIZIDINE AND BENZOINDOLIZIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF | AMERICAN BIOGENETIC SCIENCES, INC. (US) | 2000-02-03 | — | — | WO | disclosed |
| WO-1999011645-A1 | POLY(ADP-RIBOSE) POLYMERASE ('PARP') INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE | GUILFORD PHARMACEUTICALS INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0457243-A1 | Novel tricyclic compounds | SYNTEX (U.S.A.) INC. (US) | 1991-11-21 | — | — | EP | disclosed |